2 min read.Updated: 26 Oct 2021, 08:17 AM ISTLivemint
Covaxin is one of the two anti-COVID vaccines used by India in its vaccination drive across the country
Listen to this article
The World Health Organization (WHO) will meet on Tuesday to consider much-coveted emergency use approval to Covaxin, India's indigenously-made vaccine against coronavirus disease (Covid-19). According to WHO chief scientist Soumya Swaminathan, the global health body's technical advisory group will meet on October 26 to consider the emergency use listing (EUL) for Covaxin, which is already being used nationwide in the inoculation campaign against the pandemic.